Viromed Medical: Heike Perbandt, closely associated with CEO Uwe Perbandt, sells shares for EUR 38,000
Reuters2026/08/03 16:11- Heike Perbandt, closely associated with management board member Uwe Perbandt, sold Viromed Medical shares.
- Transaction priced at EUR 7.6 per share for a total volume of EUR 38,000.
- Trade date July 29, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
LNG exports plunge by 90%: Qatar’s quarterly fiscal deficit hits nearly a ten-year high, with economic contraction expected to exceed 8% this year
Qatar's budget deficit in the second quarter reached approximately $5.8 billion, marking the highest level since the end of 2016 and nearly double that of the previous quarter. Following the blockade of the Strait of Hormuz, Qatar's liquefied natural gas (LNG) exports plummeted from about 20 million tons per quarter in the same period last year to less than 2 million tons during April to June 2026. According to the IMF, Qatar's economy is expected to contract by more than 8% this year.
Colombian Peso: Downside risk bias against US Dollar – TD Securities
ETH breaks through the $2,500 mark
HBAR price slips 2% as USDOT integration claim remains unverified
Crypto prices
More
